Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Risk and Mechanism of MDR Bacterial Infection
Thomas Lodise, PharmD, PhD, discusses the need for appropriate initial therapy, how to identify patients at increased risk of multidrug resistance, and the mechanisms that lead to multidrug resistance.
Treatment of ABSSSI: Inpatient Versus Outpatient
Dr Peter L. Salgo, Dr Bruce M. Jones, and Dr Yoav Golan, consider the value of treating acute bacterial skin and skin structure infections with IV antibiotics in nonhospital settings, such as wound care centers, walk-in clinics, and infusion centers.
Oral Antibiotic Compliance for ABSSSI
Panelists emphasize the importance of patient education, patient compliance, oral antibiotic adherence, and managing expectations of prescriptions for acute bacterial skin and skin structure infections.
Future Direction and Advice for Treating MDR Bacteria
Jason Gallagher, PharmD, suggests the future direction for managing treatment and provides advice for community physicians treating multidrug-resistant bacteria.
New or Upcoming Treatment Options for MDR Bacteria
Jason Gallagher, PharmD, discusses the recently approved agents and agents in late stage development for multidrug-resistant bacteria and their potential role in treatment.
Zerbaxa and Avycaz: Considerations for Treatment
Panelists identify, in light of the available guidelines and data, the rationale behind and optimal use of currently approved cephalosporin/β-lactamase inhibitor combinations.
Is There A Link Between Lyme Disease and Chronic Fatigue Syndrome?
Samuel, Shor, MD, FACP, discusses the potential link between chronic fatigue syndrome and Lyme disease.
Cost Considerations of IV Antibiotics for ABSSSI
Panelists consider and discuss the costs of acute bacterial skin and skin structure infections patient hospital admissions, extended lengths of stay, and IV antibiotic protocol and reimbursements.
Big advances in treatment can